These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 2444868)
1. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases]. Tsuchiya K; Yamagishi H; Hamada H; Komichi H; Oka T; Tanaka T; Inaba S Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):826-31. PubMed ID: 2444868 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapeutic effects of partially purified tumor-specific transplantation antigens on pulmonary metastases of a 3-methylcholanthrene-induced sarcoma in mice: a preliminary report. Tanaka T; Pellis NR; Kahan BD J Natl Cancer Inst; 1982 Nov; 69(5):1121-6. PubMed ID: 6957656 [TBL] [Abstract][Full Text] [Related]
3. Intrasplenic administration of interleukin-2 to potentiate specific chemoimmunotherapy in tumor-bearing mice. Nomi S; Naito K; Kahan BD; Pellis NR Cancer Res; 1986 Nov; 46(11):5606-10. PubMed ID: 2875791 [TBL] [Abstract][Full Text] [Related]
4. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice. Nomi S; Naito K; Kahan BD; Pellis NR Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631 [TBL] [Abstract][Full Text] [Related]
5. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis. Kodama Y; Seyama T; Kamiya K; Yokoro K J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499 [TBL] [Abstract][Full Text] [Related]
6. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types. Papa MZ; Mulé JJ; Rosenberg SA Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517 [TBL] [Abstract][Full Text] [Related]
7. [Specific active immunotherapy of murine methylcholanthrene-induced sarcoma using a partially purified soluble tumor specific transplantation antigens]. Tanaka T; Yamagishi H; Inaba S; Kobayashi M; Kurioka H; Naito K; Hashimoto I Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):282-94. PubMed ID: 6201713 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery. Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507 [TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of a carcinogen-induced murine sarcoma with soluble tumor-specific transplantation antigens. Kahan BD; Tanaka T; Pellis NR J Natl Cancer Inst; 1980 Nov; 65(5):1001-4. PubMed ID: 6159495 [TBL] [Abstract][Full Text] [Related]
11. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism]. Gomi K; Morimoto M; Nomoto K Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454 [TBL] [Abstract][Full Text] [Related]
12. Distribution of radiolabeled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcoma. Buchsbaum DJ; Walker PC; Johnson EA Cancer Res; 1979 Sep; 39(9):3363-8. PubMed ID: 476667 [TBL] [Abstract][Full Text] [Related]
13. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential. Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788 [TBL] [Abstract][Full Text] [Related]
14. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells]. Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309 [TBL] [Abstract][Full Text] [Related]
15. Immunocompetence of splenocytes from mice bearing different-aged tumors assessed in lymphocyte-induced angiogenesis assay. Kamiński MJ; Janik P; Kamińska G Neoplasma; 1980; 27(4):363-6. PubMed ID: 6161315 [TBL] [Abstract][Full Text] [Related]
16. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas. Kumar V; Bennett M J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033 [TBL] [Abstract][Full Text] [Related]
18. In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells. Shu S; Chou T; Rosenberg SA J Immunol; 1986 May; 136(10):3891-8. PubMed ID: 3486223 [TBL] [Abstract][Full Text] [Related]
19. Retardation of postsurgical metastases with the use of extracted tumor-specific transplantation antigens and cyclophosphamide. Nomi S; Pellis NR; Kahan BD J Natl Cancer Inst; 1984 Oct; 73(4):943-50. PubMed ID: 6237215 [TBL] [Abstract][Full Text] [Related]